CYTK PRESS-RELEASE SEC Filing Analysis

Latest settled — T+20d ⚠ clustered

CYTK ▼ -4.82% at T+20d

SHORT call ✓ call won +4.82% · α vs SPY +7.95% · entry $74.29 → $70.71

Next anchor: T+60d in 7w

Last close $67.90 (close Jun 8) · +8.60% from $74.29 entry (call sign-flipped)

Entry anchored
May 6, 2026
via day open

T+1d

+3.53%

call -3.53% · α -2.70%

$76.91

settled 5w ago

T+5d

+3.94%

call -3.94% · α -2.44%

$77.22

settled 28d ago

T+20d

-4.82%

call +4.82% · α +7.95%

$70.71

settled 6d ago

T+60d

—

call — · α —

—

in 7w

Price Chart

Loading chart...

Executive Summary

Cytokinetics priced a $700 million public offering of 9.86 million shares at $71.00 per share, with an underwriter option for an additional 1.48 million shares. The offering represents approximately 7.3% dilution to existing shareholders and will close on May 8, 2026.

Key Financial Metrics

Deal Value

$700.0M

Actionable Insight

Monitor for potential downward pressure on CYTK shares as the offering closes May 8, given the dilutive nature. The stock may trade around the $71 offering price near-term. Watch for any post-offering price support from underwriters.

Key Facts

9,859,155 shares offered at $71.00/share for ~$700M gross proceeds
Underwriters have 30-day option to purchase up to 1,478,873 additional shares
Offering represents ~7.3% dilution (8.4% if greenshoe exercised)
Morgan Stanley, Goldman Sachs, J.P. Morgan, and Jefferies are joint book-runners
Closing expected May 8, 2026

Financial Impact

~$700M gross proceeds, ~7-8% dilution to existing shareholders

dilutionshare count

Risk Factors

Equity dilution of ~7-8%
Potential overhang from additional shares if greenshoe exercised
Use of proceeds not specified, adding uncertainty

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Analyst Consensus

85% bullish (27 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3289552

18 reports for CYTK

T+1T+5T+20T+60

60% Hit rate 3 of 5 directional calls best @ T+20▲ +10.38%Mar 31, 2026

Filters

Reports for CYTK — sortable, filterable
	Type				Now
Jun 1, 2026 8d ago	Insider Cluster NEUTRAL ★ 3/10	$70.91 $70.71	▼ −0.28%	▲ +0.44%	$67.90 (−4.24%)
May 20, 2026 20d ago	Insider Cluster NEUTRAL ★ 3/10	$78.06 $76.94	▼ −1.43%	▼ −1.88%	$67.90 (−13.02%)
May 11, 2026 29d ago	Press Release NEUTRAL ★ 4/10	$74.56 $74.81	▲ +0.34%	▲ +0.47%	$67.90 (−8.93%)
May 8, 2026 4w ago	Press Release BEARISH ★ 6/10	$76.91 $74.56	▲ +3.06%	▲ +3.29%	$67.90 (+11.71%)
May 7, 2026 4w ago	Press Release BEARISH ★ 6/10	$74.29 $76.91	▼ −3.53%	▼ −2.70%	$67.90 (+8.60%)
May 5, 2026 5w ago	424B5 MIXED ★ 6/10	$74.84 $74.29	▼ −0.73%	▼ −0.40%	$67.90 (−9.27%)
May 5, 2026 5w ago	8-K NEUTRAL ★ 3/10	$74.84 $74.84	· 0.00%	▲ +0.33%	$67.90 (−9.27%)
May 5, 2026 5w ago	Press Release BULLISH ★ 8/10	$77.09 $74.84	▼ −2.92%	▼ −4.30%	$67.90 (−11.92%)
May 5, 2026 5w ago	Insider Cluster MIXED ★ 4/10	$77.09 $74.84	▼ −2.92%	▼ −4.30%	$67.90 (−11.92%)
May 5, 2026 5w ago	Insider Cluster NEUTRAL ★ 3/10	$74.84 $74.29	▼ −0.73%	▼ −0.40%	$67.90 (−9.27%)

US Market Status

Market Closed — Opens in 7h 21m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access